News at CenExel
CenExel Leads Industry in Psychiatric Studies at Atlanta Center for Medical Research
SALT LAKE CITY, Jan. 14, 2020 /PRNewswire/ — CenExel Clinical Research recently strengthened its psychiatric team with the recruitment of Mark N. Lerman, MD, to serve as a principal investigator for phase I-IV studies at the Atlanta Center for Medical Research (ACMR),...
CenExel Clinical Research Acquires Research Centers of America
SALT LAKE CITY, Dec. 5, 2019 /PRNewswire/ -- CenExel Clinical Research, Inc., ("CenExel") announces the acquisition of Research Centers of America ("RCA") in Hollywood, FL, expanding their Centers of Excellence network to five of the most experienced clinical research...
TLC Presents Clinical and Preclinical Data of TLC590 at ANESTHESIOLOGY® Annual Meeting and in International Journal of Nanomedicine
TLC590 showed faster and longer lasting pain relief than ropivacaine SOUTH SAN FRANCISCO, CA and TAIPEI, Taiwan – October 21, 2019 – TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet...
CenExel Chief Scientific Advisor Todd Bertoch, MD, to Lead Session at Pain Therapeutics Summit 2019
SALT LAKE CITY, Sept. 23, 2019 /PRNewswire/ -- CenExel Clinical Research, Inc., ("CenExel" or the "Company") announced that Todd Bertoch, MD, Chief Scientic Advisor for CenExel and Chief Medical Ofcer for JBR Clinical Research, a CenExel Center of Excellence, will...
Contact Us
Ready to learn more?
Find out how our expertise can help you obtain your clinical research results, on-time and on-budget.
